NEW labeling on the cardiovascular effects related to Avandia and other diabetes meds

You'll hear about NEW labeling on the cardiovascular effects related to Avandia and other diabetes meds.

This information on safety AND efficacy will be subject to misinterpretations...some intentional and some innocent.

Efficacy. The FDA will require label changes on ALL oral diabetes meds...saying that NONE of them are proven to REDUCE cardiovascular risk.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: PA includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote